Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
199 NOK | +3.65% | +6.13% | -7.01% |
Apr. 25 | Transcript : Medistim ASA, Q1 2024 Earnings Call, Apr 25, 2024 | |
Apr. 24 | Medistim ASA Approves Dividend for the Year 2023, Payable on May 6, 2024 | CI |
Sales 2024 * | 539M 51.36M | Sales 2025 * | 563M 53.71M | Capitalization | 3.64B 348M |
---|---|---|---|---|---|
Net income 2024 * | 107M 10.2M | Net income 2025 * | 118M 11.25M | EV / Sales 2024 * | 6.62 x |
Net cash position 2024 * | 78M 7.44M | Net cash position 2025 * | 119M 11.35M | EV / Sales 2025 * | 6.26 x |
P/E ratio 2024 * |
33.9
x | P/E ratio 2025 * |
30.8
x | Employees | 151 |
Yield 2024 * |
2.26% | Yield 2025 * |
1.7% | Free-Float | 74.38% |
Latest transcript on Medistim ASA
1 day | +3.65% | ||
1 week | +6.13% | ||
1 month | +9.64% | ||
3 months | +3.92% | ||
6 months | -2.45% | ||
Current year | -7.01% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 60 | 09-08-31 | |
Director of Finance/CFO | - | 00-12-31 | |
Anne Waaler
CTO | Chief Tech/Sci/R&D Officer | 68 | 15-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 76 | 99-12-31 | |
Director/Board Member | 54 | 23-03-31 | |
Lars Rønn
BRD | Director/Board Member | 60 | 09-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 199 | +3.65% | 1,153 |
24-05-30 | 192 | -3.03% | 5,754 |
24-05-29 | 198 | +3.66% | 1,708 |
24-05-28 | 191 | -2.05% | 4,197 |
24-05-27 | 195 | +4.00% | 2,144 |
Real-time Oslo Bors, May 31, 2024 at 10:45 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.01% | 347M | |
+7.01% | 217B | |
+11.01% | 190B | |
+19.20% | 143B | |
+30.79% | 111B | |
+1.48% | 64.59B | |
+13.95% | 52.36B | |
-0.16% | 48.45B | |
-6.20% | 38.03B | |
+0.91% | 35.6B |
- Stock Market
- Equities
- MEDI Stock